medical device guru

Biologics, Wound Care, Infection Prevention

Smith & Nephew to Buy Osiris Therapeutics for $660 Million

Smith & Nephew said today that it agreed to put $660 million on the table to acquire Osiris Therapeutics and its regenerative medicine portfolio. The British orthopedics and wound care giant said the $19-per-share deal is a 37% premium on the 90-day volume-weighted...

March 12, 2019

Biologics, Wound Care, Infection Prevention

Fish-Skin Wound Care Company Gets Swiss Approval, Makes Acquisition

Kerecis, the company pioneering the use of fish skin in tissue regeneration, today received a notice from Swiss healthcare authorities that the company’s lead product, Kerecis Omega3 Wound, will be reimbursed in Switzerland. The company will also acquire the Swiss life-science...

February 11, 2019

Biologics, Wound Care, Infection Prevention

FDA Grants De Novo Authorization to Pressure Ulcer Risk Assessment Device

Bruin Biometrics, LLC has been granted U.S. Food and Drug Administration marketing authorization for the SEM Scanner, a wireless handheld device that is indicated for use as an adjunct to the standard of care when assessing patients who are at...

January 7, 2019

Biologics, Wound Care, Infection Prevention

AVITA Medical’s “Spray-On Skin” Approved to Treat Serious Burns

AVITA Medical, a Valencia, California firm, won FDA approval for its remarkable RECELL Autologous Cell Harvesting Device for serious burns in adult patients. In preparation for treatment, a small healthy piece of the patient’s skin sample is taken, from which...

September 25, 2018

Biologics, Wound Care, Infection Prevention

Avista to acquire Organogenesis

Avista Healthcare Public Acquisition Corp., a publicly traded special purpose acquisition company, and Organogenesis Inc., a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care, Surgical and Sports Medicine markets,...

August 20, 2018

Biologics, Wound Care, Infection Prevention

MolecuLight’s First-of-its-kind Handheld Wound Imaging Device Receives FDA De Novo Clearance

MolecuLight Inc. achieved a major regulatory milestone permitting expansion into the United States market. FDA has granted De Novo clearance for the ground-breaking wound fluorescence imaging device, the MolecuLight i:X. The device digitally captures and documents fluorescence information from wounds and surrounding tissue...

August 16, 2018

Biologics, Wound Care, Infection Prevention

Innovative Bedside Biologic Maker RedDress Receives 510(k) for RD1 System

RedDress Ltd announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its RD1 system. RD1 is an innovative wound care product which enables health care providers to produce in real time, in vitro whole...

July 16, 2018

Biologics, Wound Care, Infection Prevention

Implantable Organ Developer Miromatrix Raises Additional $15.7M in Series B Funding

July 12, 2018 – Press Release by Miromatrix Medical Miromatrix Medical Inc. is excited to announce it recently raised $15.7 million in Series B-2 funding, surpassing its goal of $10 million. As part of the round, Miromatrix also welcomed its...

July 12, 2018

Biologics, Wound Care, Infection Prevention

MiMedx CEO and President Out Amid Corporate Turmoil

MiMedx, the Marietta biopharma company rocked by allegations of inflated earnings and improper sales practices, said Monday the company’s longtime chairman and CEO has resigned. Parker H. “Pete” Petit, a fixture in metro Atlanta’s business community, resigned both as CEO and...

July 2, 2018